Health Canada Intelligence

Know what Health Canada changed.
Before it matters.

RegSignal monitors Health Canada guidance documents across drug products, biologics, and medical devices — and delivers plain-English summaries of what changed, when, and why it matters to your program.

Change Feed Monitoring 302 documents
Biologics 2026-04-15
Regulatory roadmap for biologic (Schedule D) drugs in Canada
The Lot Release Program section was revised to clarify that lot release requirements apply only when a biologic drug has been placed in the Lot Release Program, rather than applying to every lot of every biologic.
AI summary
Medical Devices 2026-04-02
Pre-market guidance for machine learning-enabled medical devices
Substantially revised the licence terms and conditions section to clarify the legal basis, purpose, and decision-making criteria for imposing or amending terms and conditions on ML-enabled medical devices.
AI summary
Drug Products 2026-03-30
Non-prescription Drugs: Category IV Monographs
Updated to streamline submission requirements and significantly expand the list of available Category IV Monographs with new entries including First Aid Antiseptics, Oral Health Products, and revised Sunscreen Monographs.
AI summary

Updated daily · Tracking changes since March 16, 2026

What RegSignal does

∂

Change Detection

Daily monitoring of Health Canada guidance document indexes. Every update is captured, diffed, and timestamped — so nothing slips through between your manual checks.

◈

Plain-English Summaries

AI-generated one-sentence summaries of every detected change. Understand what shifted and whether it affects your active program — without reading the diff yourself.

⌬

Targeted Alerts

Filter by product class: Drug Products, Biologics, Medical Devices. Get notified about the updates that are relevant to your submission, not every change across all of HC.

The problem

Your team shouldn't need Google Alerts for a $50M submission.

Health Canada updates guidance documents with little notice and no change tracking. The enterprise tools that solve this cost $50K+/year and are built for global pharma, not a two-person regulatory team at a 40-person Victoria biotech.

How most teams track HC guidance today Current state
01
Set up Google Alerts for "Health Canada guidance"
Noisy, incomplete, misses document-level changes
🔔
02
Bookmark canada.ca guidance pages and check manually
Weekly if diligent — monthly in practice
🔖
03
Maintain a spreadsheet of relevant documents and dates
Usually falls out of date within a quarter
📊
04
Call a regulatory consultant when questions arise
Expensive and slow
📞
05
Find out a guidance changed during a deficiency review
Months of submission delay
⚠️

Built for Regulatory Affairs teams at clinical-stage Canadian biotechs.

RegSignal is in early access. If you're a regulatory affairs professional at a Canadian biotech, we'd like to talk — and to make sure the product solves real problems before we charge for it.

✓ You're on the list — we'll be in touch shortly.

Or reach the founder directly: joe@regsignal.io

Product

Overview Features How it works Early Access

Company

Contact